Bid Publish Date
13-Jan-2025, 3:44 pm
Bid End Date
25-Feb-2025, 4:00 pm
Location
Progress
RAQuantity
22380
Category
Diethylcarbamazine 50mg tab
Bid Type
Two Packet Bid
Public procurement opportunity for Indian Army Diethylcarbamazine 50mg tab, Enalapril 2. 5mg tab, ED Fluconazole 0. 3percent, ED Flurbiprofen Sodium 0. 3 percent 5ml, Fusidic acid Oint cream, Levenorgestrol 0. 25 plu sEthnylestradoil 0. 05mg pack of 21 tab, Lamotrigine 50mg tab, Methotrexate 10mg tab, Megesterol Acetate 40mg tab in CENTRAL DELHI, DELHI. Quantity: 22380 issued by. Submission Deadline: 25-02-2025 16: 00: 00. View full details and respond.
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
Diethylcarbamazine 50mg tab , Enalapril 2.5mg tab , ED Fluconazole 0.3percent , ED Flurbiprofen Sodium 0.3 percent 5ml , Fusidic acid Oint cream , Levenorgestrol 0.25 plu sEthnylestradoil 0.05mg pack of 21 tab , Lamotrigine 50mg tab , Methotrexate 10mg tab , Megesterol Acetate 40mg tab
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS
Diethylcarbamazine 50mg tab
Diethylcarbamazine 50mg tab
Enalapril 2.5mg tab
Enalapril 2.5mg tab
ED Fluconazole 0.3percent
ED Fluconazole 0.3%
ED Flurbiprofen Sodium 0.3 percent 5ml
ED Flurbiprofen Sodium 0.3% 5ml
Fusidic acid Oint cream
Fusidic acid Oint cream
Levenorgestrol 0.25 plu sEthnylestradoil 0.05mg pack of 21 tab
Levenorgestrol 0.25+Ethnylestradoil 0.05mg pack of 21 tab
Lamotrigine 50mg tab
Lamotrigine 50mg tab
Methotrexate 10mg tab
Methotrexate 10mg tab
Megesterol Acetate 40mg tab
Megesterol Acetate 40mg tab
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | Diethylcarbamazine 50mg tab | Diethylcarbamazine 50mg tab | 300 | no | [email protected] | 15 | |
| 2 | Enalapril 2.5mg tab | Enalapril 2.5mg tab | 7,800 | no | [email protected] | 15 | |
| 3 | ED Fluconazole 0.3percent | ED Fluconazole 0.3% | 30 | bott | [email protected] | 15 | |
| 4 | ED Flurbiprofen Sodium 0.3 percent 5ml | ED Flurbiprofen Sodium 0.3% 5ml | 480 | no | [email protected] | 15 | |
| 5 | Fusidic acid Oint cream | Fusidic acid Oint cream | 540 | no | [email protected] | 15 | |
| 6 | Levenorgestrol 0.25 plu sEthnylestradoil 0.05mg pack of 21 tab | Levenorgestrol 0.25+Ethnylestradoil 0.05mg pack of 21 tab | 30 | pkt | [email protected] | 15 | |
| 7 | Lamotrigine 50mg tab | Lamotrigine 50mg tab | 5,840 | no | [email protected] | 15 | |
| 8 | Methotrexate 10mg tab | Methotrexate 10mg tab | 3,060 | no | [email protected] | 15 | |
| 9 | Megesterol Acetate 40mg tab | Megesterol Acetate 40mg tab | 4,300 | no | [email protected] | 15 |
Experience Criteria
Past Performance
Bidder Turnover
Certificate (Requested in ATC)
OEM Authorization Certificate
OEM Annual Turnover
Additional Doc 1 (Requested in ATC)
Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Start
12-Apr-2025, 12:00 pm
End
14-Apr-2025, 12:00 pm
Duration: 48 hours
Reverse Auction Document
✅ RA concluded. Check financial results for final rankings.
| S.No | Seller | Item | Date | Status |
|---|---|---|---|---|
| 1 | ********** Under PMA | - | 25-02-2025 10:37:38 | |
| 2 | ********** Under PMA | - | 22-02-2025 16:54:43 | |
| 3 | ********** Under PMA | - | 04-02-2025 18:30:55 | |
| 4 | ********** Under PMA | - | 25-02-2025 15:59:52 | |
| 5 | ********** Under PMA | - | 23-02-2025 09:40:11 | |
| 6 | ********** Under PMA | - | 25-02-2025 13:18:53 | |
| 7 | ********** Under PMA | - | 22-02-2025 11:59:41 | |
| 8 | ********** Under PMA | - | 21-02-2025 12:28:30 | |
| 9 | ********** Under PMA | - | 22-02-2025 15:33:19 | |
| 10 | ********** Under PMA | - | 25-02-2025 14:22:02 | |
| 11 | ********** Under PMA | - | 22-02-2025 17:26:09 | |
| 12 | ********** Under PMA | - | 22-02-2025 16:03:14 | |
| 13 | ********** Under PMA | - | 22-02-2025 19:34:42 | |
| 14 | ********** Under PMA | - | 25-02-2025 15:26:58 | |
| 15 | ********** Under PMA | - | 19-02-2025 22:32:02 | |
| 16 | ********** Under PMA | - | 25-02-2025 13:22:54 | |
| 17 | ********** Under PMA | - | 22-02-2025 13:46:22 | |
| 18 | ********** Under PMA | - | 24-02-2025 15:55:51 |
Key insights about DELHI tender market
The eligibility requirements include being a registered entity and having the capability to fulfill the procurement needs specified in the tender. Bidders must provide evidence of compliance with experience and previous performance standards, as well as financial turnover documentation. Additionally, specific certifications must accompany the tender submissions.
Bidders must submit a range of required certificates including OEM authorizations, proof of past performance, and financial turnover, as outlined in the tender documents. It is crucial that all certifications adhere to established industry standards to ensure compliance.
The registration process involves submitting all necessary documents and certifications as indicated in the tender submission guidelines. Bidders must ensure that their entity is registered under the relevant trade laws and provides the required documentation to prove eligibility.
Accepted document formats include PDF and other specified formats detailed in the tender documentation. Bidders are encouraged to ensure that all documents such as compliance certifications and financial documents are presented in the formats listed to avoid non-compliance.
The technical specifications for the medicines are outlined specifically in the tender document. Bidders must ensure that all products meet the required dosage and formulation standards to qualify for evaluation.
Products must comply with established quality standards including compliance with applicable pharmaceutical regulations and certifications. Bidders should demonstrate compliance with all necessary quality assurance measures during the evaluation process.
Bidders must demonstrate compliance with all compliance requirements outlined in the tender. This includes adhering to regulations related to product quality, documentation, and financial transparency.
Performance security requirements generally include a specified percentage of the contract value to ensure that successful bidders fulfill their contractual obligations. Detailed requirements are provided in the tender documentation.
Payment terms, including schedules and methods, are detailed in the tender documents. Bidders are advised to review these terms carefully to understand their obligations and rights regarding payment.
Price evaluation considerations will be based on the overall competitiveness of the tender submissions, including pricing, compliance with technical specifications, and the supplier's capability to meet delivery timelines.
Bidders can submit documents electronically through the specified submission portal indicated within the tender instructions. All submissions must comply with the guidelines laid out in the tender documentation.
Bidders should be aware of all key timelines and deadlines stated in the tender documents. Timely submissions are critical to the consideration process, and adherence to these schedules is essential.
The evaluation and selection process will involve rigorous examination of bids against the outlined criteria. Bids will be assessed on technical compliance, cost-effectiveness, and overall capability.
Notification of results will typically occur following the completion of the evaluation process, with communications directed to all participating bidders according to the timelines outlined in the tender.
The tender includes specific provisions that favor Micro, Small, and Medium Enterprises (MSEs), including exemptions from certain criteria related to experience and financial turnover. This encourages wider participation from smaller entities.
Startups may benefit from special provisions related to compliance requirements, including relief from stringent documentation needs that typically apply to more established entities. They are encouraged to provide supporting documentation validating their eligibility for these exemptions.
The tender aligns with 'Make in India' policies by promoting local production and sourcing of pharmaceutical products. Bidders are encouraged to meet local content requirements and contribute to fostering domestic manufacturing capabilities in pharmaceuticals.
Sign up now to access all documents
Main Document
BOQ
BOQ
ATC
GEM_GENERAL_TERMS_AND_CONDITIONS